Methylphenidate for adults with ADHD
Part of Mental health clinical trials.
This trial tests whether methylphenidate (a stimulant medicine) helps adults with attention-deficit/hyperactivity disorder (ADHD). It is checking safety and effectiveness for people who can take the immediate-release form of the medicine.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are White Brazilian and of European descent
- A doctor has diagnosed you with ADHD based on DSM-IV criteria
- You are able to take immediate-release methylphenidate (IR-MPH) right away
- You do NOT have a medical reason you can’t safely take IR-MPH
- You are NOT currently taking stimulant medicines
- You do NOT have certain brain/nerve conditions or a history of psychosis
- Your IQ score is 70 or higher
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how methylphenidate (a common ADHD medicine) affects the body and brain in people with ADHD. You may be able to join if you have an ADHD diagnosis and meet specific health and medication-related requirements.
This Phase 3 study tests how methylphenidate affects brain signals and attention in adults with ADHD, and in adults with mood-related attention problems. It also includes healthy volunteers to compare brain responses during brain scanning.
This study looks at how the body processes methylphenidate (Ritalin) in adults with ADHD, comparing people with obesity (BMI 30 or higher) to those without. It aims to find out if weight affects the medication levels, which could help doctors adjust doses for better treatment.
This study tests if the medication methylphenidate (commonly used for ADHD) can help manage attention and behavior problems in people with KBG syndrome. Each person acts as their own test case to see if the drug works for them.
This study looks at whether the medication methylphenidate (often used for ADHD) can help people who have both ADHD and an addiction. It aims to see if the medicine is safe and works well for people with both conditions.
This trial studies whether a genetic difference called “carboxylesterase 1” changes how methylphenidate (a common ADHD medicine) works for children with ADHD. It’s a single-dose test, meant to help understand why some children respond differently to ADHD medication.
Hear when a new Attention Deficit Disorder With Hyperactivity trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.